MK-6916
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
March 05, 2026
A clinical trial of MK-6916 in healthy participants (MK-6916-010)
(clinicaltrialsregister.eu)
- P1 | N=54 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1 trial • Pain
June 27, 2025
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
(clinicaltrials.gov)
- P1 | N=40 | Active, not recruiting | Sponsor: Merck Sharp & Dohme LLC | N=30 ➔ 40
Enrollment change
March 23, 2026
A clinical trial of MK-6916 in healthy participants (MK-6916-010)
(clinicaltrialsregister.eu)
- P1 | N=54 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Pain
May 15, 2025
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
(clinicaltrials.gov)
- P1 | N=30 | Active, not recruiting | Sponsor: Merck Sharp & Dohme LLC | Recruiting ➔ Active, not recruiting
Enrollment closed
October 08, 2026
A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)
(clinicaltrials.gov)
- P2 | N=380 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P2 trial • Pain
October 08, 2026
A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012)
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1 trial
February 11, 2025
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1 trial
March 17, 2025
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open
August 27, 2025
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
(clinicaltrials.gov)
- P1 | N=37 | Completed | Sponsor: Merck Sharp & Dohme LLC | Active, not recruiting ➔ Completed
Trial completion
1 to 9
Of
9
Go to page
1